Harmonica Playing Improves Quality of Life in Patients With COPD
NCT ID: NCT03442140
Last Updated: 2026-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2017-08-01
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Harmonica Playing in Improving Lung Function Among COPD Patients
NCT05995847
Respiratory Muscle Exercise Training in COPD Patients
NCT01747694
Muscle Dysfunction in Patients With Chronic Obstructive Lung Disease (COPD): the Role of Sympathetic Activation
NCT01750489
Resistance Training to Prehabilitate Patients With Chronic Obstructive Pulmonary Disease
NCT02860728
Low Load, High-repetitive Elastic Band Resistance Training in COPD
NCT02283580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
They will be trained to play the Harmonica and practice as a group during a twelve week program, for one hour a day, one day a week with the Instructors, one is a Registered Respiratory Therapist and the other is a music therapist, who will evaluate their ability and offer assistance. The music therapist will meet individually with each study participant at the beginning of the study to assess participants' harmonica playing ability.
They are required to practice at home (individually) in between classes for 30 minutes five days a week outside the formal training hour with the group. They may use oxygen as prescribed by their physician during the training. The training booklet includes information to help the subject with COPD understand how this program is designed to help them. They will also be given instructions on how to clean the harmonica and infection control measures to use during the program to prevent infections that could occur using the harmonica.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Patients who completed the Baylor Martha Foster Lung Center Pulmonary Rehabilitation Program at least six months ago will participate in the 12-week harmonica program
Harmonica playing
Patients will play the harmonica for up to 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Harmonica playing
Patients will play the harmonica for up to 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Practice playing at home 30 minutes x 5 days a week
* Documented diagnosis of COPD
* Ability to perform spirometry, IC, MIP, and MEP maneuver and 6 minute walk
* Willing to complete depression, quality of life, shortness of breath, functional evaluation questionnaires
* Willing to perform in a group setting
Exclusion Criteria
* Inability to perform spirometry, IC, MIP and MEP maneuver
* Inability to commit to weekly one hour sessions for 12 weeks and practice for 5 days/week.
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baylor Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Millard
Role: PRINCIPAL_INVESTIGATOR
Baylor Health Care System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baylor University Medical Center
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
017-135
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.